Cyclosporine/Rebamipide

环孢素/雷巴米特

Report date: 2026/01/21 17:01:09

Base Information

Drug NameCyclosporine/Rebamipide
Drug Alias Name环孢素A/瑞巴派特
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionProstaglandin agonistsFree radicals scavengersSodium/bile acid cotransporter inhibitors +[7] 
TargetsProstaglandinFree radicalsSodium/bile acid cotransporter +[6] 
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes CyclosporineRebamipide
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A